Hazrat Bilal | Microbiology | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Hazrat Bilal | Microbiology | Best Researcher Award 

Associate Researcher/professor, at Jiangxi Cancer Hospital and Institute, China.

Dr. Hazrat Bilal is an accomplished Associate Researcher and Professor at Jiangxi Cancer Hospital and Institute, China. With a Ph.D. in Ecology specializing in Microbiology, he is at the forefront of antimicrobial resistance (AMR), fungal infections, and host–microbiome interactions in oncology. 📊 His research spans predictive AI modeling, epidemiology, and infectious diseases in immunocompromised patients. Dr. Bilal’s scientific acumen is reflected in his extensive publication record (40+ SCI-indexed articles) and editorial contributions. 🧫 As a dedicated academic, he teaches medical laboratory science and mentors early-career researchers. His work supports global efforts to tackle fungal pathogens and optimize antimicrobial stewardship in clinical settings. 🌍 He maintains collaborations with top institutions and contributes regularly as a peer reviewer for major journals. His research not only addresses clinical gaps but also fuels healthcare innovation in microbiome and AMR analytics.

Professional Profile

Scopus

ORCID

🎓 Education

Dr. Hazrat Bilal holds a Ph.D. in Ecology with a core focus on Microbiology, equipping him with an interdisciplinary foundation for his research in clinical microbiology and infectious diseases. 🎓 Throughout his academic journey, he has cultivated a deep understanding of microbial ecology, host–pathogen interactions, and molecular diagnostics. His doctoral training emphasized fungal genomics and resistance mechanisms, preparing him for translational research in hospital and clinical environments. He complemented his Ph.D. with intensive postdoctoral work at the Second Affiliated Hospital of Shantou University Medical College, where he further explored cancer-related mycological disorders and resistance trends. 🧬 Dr. Bilal’s education combined theoretical expertise with applied research, allowing him to emerge as a leader in the field of microbiome analytics, medical mycology, and antimicrobial stewardship—areas crucial for contemporary medical microbiology. His teaching credentials further enrich his ability to train students and healthcare professionals in evidence-based laboratory practices.

🧪 Experience

Dr. Bilal’s professional journey reflects a dynamic blend of research, teaching, and clinical consultancy. 🔬 He is currently an Associate Researcher/Professor at Jiangxi Cancer Hospital and Institute, where he leads cutting-edge projects in fungal infections and AMR surveillance. Prior to this, he served as a postdoctoral researcher at the Second Affiliated Hospital of Shantou University Medical College, contributing to landmark studies on cancer-related microbial infections. 💼 His experience extends to the classroom, where he delivers medical laboratory science courses in English, fostering global academic collaboration. He has consulted on hospital-based AMR stewardship protocols and contributed to AI-driven resistance modeling systems. His ongoing partnerships with Chinese and international institutions showcase his ability to manage large-scale interdisciplinary projects. 🌐 As an editorial board member and reviewer for 15+ SCI journals, Dr. Bilal’s insights shape the peer-review process. His career demonstrates a relentless commitment to healthcare improvement through science and innovation.

🔬 Research Interests

Dr. Hazrat Bilal’s research interests revolve around clinical microbiology, antimicrobial resistance, and fungal infections in oncology patients. 🧫 He is deeply engaged in studying host–pathogen interactions, particularly in immunocompromised individuals, using genomic and microbiome profiling techniques. His ongoing projects include fungal microbiota analysis in kidney cancer, AI-based predictive AMR modeling, and epidemiological studies on Candida albicans. 🧠 His approach integrates clinical data, computational tools, and epidemiological modeling to derive actionable insights for therapeutic decision-making. He also explores the microbiome’s role in tumorigenesis and infection susceptibility. 🚀 Dr. Bilal is passionate about improving diagnostic strategies through non-invasive fungal detection and bioinformatics pipelines. His work supports precision medicine by enabling timely and targeted interventions for infection control. His translational research ethos ensures real-world impact, especially in resource-constrained clinical settings. The intersection of artificial intelligence, microbiology, and oncology defines his innovative and forward-looking research paradigm.

🏆 Awards

Dr. Bilal has been a consistent contributor to scientific innovation and academic excellence, which has positioned him as a strong candidate for awards like the Best Researcher Award. 🥇 His scholarly achievements include recognition as a first author in 16 high-impact SCI articles and invitations to editorial boards of prestigious journals such as Frontiers in Environmental Microbiology. He has also written multiple book chapters and conducted reviews for over 15 international journals, underscoring his reputation as a critical voice in the field. 📘 His academic contributions have enabled better infection management protocols in oncology, winning accolades from collaborating institutions. He is regularly invited to speak and contribute at research symposia, where he presents findings on AMR, fungal resistance, and microbiome analytics. His influence extends across disciplines and geographies, supported by a citation index that reflects both the depth and reach of his work (h-index: 14, Google Scholar Citations: 731). 🧠

📚 Top Noted Publications

Dr. Bilal has authored 40 SCI-indexed articles, with 16 as first or corresponding author, reflecting his significant role in advancing knowledge in microbial resistance and clinical mycology. 🔍 His most cited works include:

1. Candida albicans biofilm resistance mechanisms in oncology patients

Journal: Frontiers in Microbiology
Year: 2023
Citations: 95

Summary:
This study explores how Candida albicans biofilms exhibit resistance to antifungal treatments, particularly in oncology patients undergoing chemotherapy or immunosuppressive therapy. It highlights mechanisms such as overexpression of efflux pumps (CDR1, MDR1), extracellular matrix shielding, quorum sensing modulation, and genetic plasticity. The paper also discusses clinical implications, including the challenges in eradicating biofilm-related infections in immunocompromised hosts and potential strategies like combination therapy and biofilm-disrupting agents.

2. Predictive modeling of AMR using artificial intelligence: a hospital-based study

Journal: Scientific Reports
Year: 2022
Citations: 68

Summary:
This paper presents a machine learning framework for predicting antimicrobial resistance (AMR) in hospital pathogens using electronic health records (EHRs) and microbiological data. The authors tested various algorithms (e.g., random forest, gradient boosting, neural networks), with ensemble models showing high predictive accuracy for AMR trends. The study emphasizes the potential of AI in early intervention, empirical therapy optimization, and hospital infection control.

3. Fungal microbiota diversity in renal cancer patients

Journal: Journal of Medical Mycology
Year: 2021
Citations: 53

Summary:
This research investigates the composition of the mycobiome in renal cancer patients using high-throughput sequencing. It found significant alterations in fungal diversity compared to healthy controls, including enrichment of Candida, Malassezia, and Cladosporium species. The paper discusses possible interactions between fungal dysbiosis and cancer progression, immune modulation, and therapy outcomes, suggesting that fungal microbiota could be potential biomarkers or therapeutic targets.

4. Resistance trends in non-albicans Candida: a clinical review

Journal: BMC Infectious Diseases
Year: 2020
Citations: 47

Summary:
This clinical review summarizes resistance patterns in non-albicans Candida species (C. glabrata, C. tropicalis, C. parapsilosis, C. krusei), highlighting emerging resistance to azoles and echinocandins. The review provides insight into regional resistance trends, molecular mechanisms (e.g., FKS mutations), and challenges in antifungal stewardship. It emphasizes the need for species-specific treatment protocols and routine susceptibility testing.

5. Clinical surveillance of antifungal drug efficacy in cancer therapy

Journal: Antimicrobial Agents and Chemotherapy
Year: 2019
Citations: 39

Summary:
This prospective surveillance study evaluates antifungal efficacy in cancer patients across multiple centers. It assessed drug performance (e.g., fluconazole, voriconazole, amphotericin B) against various fungal pathogens, tracking treatment outcomes, resistance development, and adverse effects. The findings support the continuous monitoring of antifungal efficacy and highlight a trend of rising resistance in oncology settings, especially in hematologic malignancy cases.

Conclusion

Dr. Hazrat Bilal is highly deserving of the Best Researcher Award based on his strong research productivity, interdisciplinary focus, and contributions to emerging challenges in clinical microbiology and AMR, especially within the oncology context. His academic leadership, collaborative projects, and commitment to scientific advancement make him a strong candidate for recognition.

Nadia Jaidane | Microbiology | Women Researcher Award

Posted on by sciencefather

Dr. Nadia Jaidane | Microbiology | Women Researcher Award

Postdoctoral researcher, at Faculty of medecine Sousse, Tunisia.

🌟 Dr. Nadia Jaidane is a distinguished microbiologist specializing in pharmaceutical sciences. Born on September 17, 1976, in Tunisia, she has made significant contributions to the field of clinical microbiology and bacterial resistance research. With over two decades of experience, she is currently a Professor of Paramedical Education at the Higher School of Health Sciences and Techniques of Monastir. Her research focuses on antimicrobial resistance, hospital hygiene, and infectious diseases, contributing to numerous scientific publications and international collaborations. She actively participates in scientific congresses and professional organizations, reinforcing her expertise in the field.

Professional Profile

Scopus

ORCID

Education

🎓 Dr. Jaidane holds a Ph.D. in Pharmaceutical Sciences, specializing in Microbiology, awarded with “Very Honourable Distinction” from the Faculty of Pharmacy of Monastir, Tunisia, in collaboration with the University of Paris-Sud. She also holds multiple master’s degrees in hospital hygiene, food quality and bioprocesses, and life and earth sciences, all obtained with honors. Additionally, she has a Graduate Diploma in Medical Biology and a Complementary Diploma in Medical Pedagogy from Faculty of Medicine Ibn El Jazzar – Sousse. Her diverse academic background equips her with expertise in microbiology, medical education, and quality management in healthcare.

Experience

💼 Dr. Jaidane has held several key roles in academia and healthcare. Since 2013, she has been a Professor of Paramedical Education, training students in medical biology. Previously, she served as a Hygienist Technician at the Department of Prevention and Security of Care at Sahloul University Hospital, where she contributed to infection control and hospital hygiene. She also worked as an Epidemiologist Technician and a Sleep/Neurodiagnostic Technician, demonstrating her versatility in medical sciences. Her extensive experience bridges research, clinical practice, and education in microbiology and public health.

Research Interests

📚 Dr. Jaidane’s research interests focus on antimicrobial resistance, infectious diseases, and hospital hygiene. She has conducted genomic studies on resistant bacterial strains, particularly Klebsiella pneumoniae and Acinetobacter baumannii, contributing to the understanding of bacterial resistance mechanisms. Her work also explores epidemiological trends in nosocomial infections and antibiotic consumption patterns in healthcare settings. Through her research, she aims to develop strategies for controlling and preventing bacterial infections in hospitals, thereby improving patient safety and public health outcomes.

Awards & Recognitions

🏆 Dr. Jaidane has received multiple honors throughout her career. She earned “Very Honourable Distinction” for her Ph.D. and “Honors” in all her master’s degrees. She has been an active member of scientific congresses, contributing to the advancement of microbiology and hospital hygiene. Additionally, she has played a pivotal role in several epidemiological studies on infection control, receiving recognition for her contributions to healthcare safety and antimicrobial resistance research.

Top Noted Publications

📚 Dr. Jaidane has authored multiple peer-reviewed publications in high-impact journals, including:

  • Genomic analysis of in vivo acquired resistance to colistin and rifampin in Acinetobacter baumannii

    • Journal: International Journal of Antimicrobial Agents, 2018

    • Citations: 50+

    • Summary: This study investigates genetic mechanisms underlying colistin and rifampin resistance in A. baumannii through whole-genome sequencing. It identifies mutations contributing to resistance development during treatment.

  • Genomic Insights into Colistin-Resistant Klebsiella pneumoniae

    • Journal: Antimicrobial Agents and Chemotherapy, 2018

    • Citations: 40+

    • Summary: This paper explores genetic adaptations in K. pneumoniae strains resistant to colistin, revealing mutations in genes associated with lipid A modification and efflux pumps.

  • Whole genome sequencing of NDM-1-producing ST85 Acinetobacter baumannii

    • Journal: International Journal of Antimicrobial Agents, 2018

    • Citations: 35+

    • Summary: The study characterizes A. baumannii ST85 strains harboring the NDM-1 carbapenemase gene, highlighting their genomic features and resistance determinants.

  • Temporal Variation in Antibiotic Resistance of Acinetobacter baumannii

    • Journal: The Open Microbiology Journal, 2019

    • Citations: 20+

    • Summary: This research analyzes the changing patterns of antibiotic resistance in A. baumannii over time, providing insights into epidemiological trends and resistance evolution.

  • Epidemiology of resistance and phenotypic characterization of carbapenem resistance

    • Journal: African Health Sciences, 2019

    • Citations: 15+

    • Summary: The study describes the epidemiology and resistance mechanisms of carbapenem-resistant bacteria, emphasizing phenotypic and molecular characterization.

  • Ten golden rules for optimal antibiotic use in hospital settings

    • Journal: World Journal of Emergency Surgery, 2023

    • Citations: 10+

    • Summary: This paper outlines key principles for antimicrobial stewardship in hospitals, aiming to reduce resistance development and improve patient outcomes.

Conclusion

Dr. Nadia Jaidane is a highly qualified candidate with a strong research portfolio in microbiology and antimicrobial resistance. Her extensive academic background, impactful publications, and active engagement in the scientific community make her a strong contender. To maximize her chances, demonstrating leadership in grant-funded projects, winning more international awards, and emphasizing research impact on public health policy would further strengthen her application.

Suraj Pal | Microbiology | Best Researcher Award

Posted on by sciencefather

Mr. Suraj Pal | Microbiology | Best Researcher Award 

Suraj Pal, at Maharishi Markandeshwar (Deemed to be University), Mullana- Ambala, India.

Suraj Pal is a dedicated microbiologist and research enthusiast with a strong academic background and a passion for understanding microbial and viral behavior. He has published work on the therapeutic potential of Aloe vera and actively pursues research on microbial applications to combat environmental and health challenges. With experience in customer care, he has developed skills in problem-solving and teamwork. Suraj is driven to make impactful contributions to microbiology, aiming to inspire future generations through innovative solutions for a sustainable tomorrow.

Profile

Google Scholar

ORCID

Education 📜🎓

Suraj Pal is currently pursuing an M.Sc. in Microbiology at Maharishi Markandeshwar (Deemed to be University) in Mullana, Ambala, where he has maintained an impressive CGPA of 9.17 and 9.14 in his first and second semesters, respectively, and is expected to graduate in June 2025. Previously, he completed a B.Sc. in Medical Laboratory Sciences from Chandigarh Group of Colleges, Jhanjeri, Mohali, with a CGPA of 7.66 in 2023. His academic journey began with a solid foundation at Jawahar Navodaya Vidyalaya, Sagga Karnal, where he achieved an 88% score in his Senior School Certificate Examination (2020) and an 88.6% in his Secondary School Examination (2018).

Professional Experience 🌍💼

Suraj has hands-on experience in customer service, having worked as a Customer Care Executive at Teleperformance Private Limited in Mohali, India. During this six-month role, he developed key communication and problem-solving skills, learning to identify and address customer issues effectively and build rapport through empathy. His responsibilities included data management using Excel, maintaining a record of daily interactions, and supporting team collaboration to achieve high service standards.

Research Interests 🔬🧬

Driven by his passion for microbiology, Suraj’s research interests focus on microbial solutions for pressing environmental and health challenges. Key areas of interest include exploring microbial access to nutrients to delay eutrophication, studying antimicrobial effects of plant secondary metabolites, investigating the role of microbes in industrial processes, and developing microbial alternatives to antibiotics. He is particularly fascinated by molecular recombinant microbes for producing eco-friendly, biodegradable products and has a keen interest in recombinant vaccines.

Publication Top Notes 📚📅

Title: The Effect of Aloe vera on Skin and Its Commensals: Contribution of Acemannan in Curing Acne Caused by Propionibacterium acnes

  • Authors: Suraj Pal, Mayank Raj, Medha Singh, Kumar Saurav, Chetan Paliwal, Subhasish Saha, Anil Kumar Sharma, and Manoj Singh.
  • Published In: Microorganisms
  • Publisher: MDPI
  • Volume/Issue: Volume 12, Issue 10
  • Year of Publication: 2024
  • DOI: 10.3390/microorganisms12102070
  • Abstract: This article explores the efficacy of acemannan, a compound in Aloe vera, for its antimicrobial and anti-inflammatory effects on acne-causing bacteria, Propionibacterium acnes. It evaluates Aloe vera‘s potential to serve as a sustainable and natural remedy, balancing skin flora and reducing acne inflammation.

Title: Effect of Aloe vera Leaf Extract on Normal Skin Commensalism

  • Presentation Type: Oral Presentation
  • Conference: 4th International Conference on Recent Trends in Life Sciences and Biotechnology (ICRTLSB-2K23)
  • Organized By: International Association of Zoologists
  • Dates: December 12–14, 2023
  • Location: Conference proceedings published in IAZ with ISBN: 978-93-6056-834-8
  • Abstract: This presentation delved into how Aloe vera leaf extract influences the commensal bacteria of healthy skin, showing its potential to balance skin microbiota, benefiting overall skin health.

Conclusion

Suraj Pal is a promising candidate for the Best Researcher Award in Microbiology due to his strong academic background, dedication to meaningful research, and impactful work on Aloe vera’s role in skincare. His research addresses practical challenges and aligns with sustainable health solutions, making him well-suited for recognition in his field. While building on his current achievements by expanding his publication record and deepening technical skills could further enhance his impact, his innovative research interests and commitment to improving public health and environmental sustainability make him a compelling choice for the award.